Search Medical Condition
Please enter condition
Please choose location from dropdown

Diabetes Prevention Clinical Trials

A listing of Diabetes Prevention medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (65) clinical trials

Intranasal Insulin for Prevention of Type 1 Diabetes

Children born in Turku, Oulu and Tampere university cities in Finland are screened at birth for the HLA-DQB1 and DQA1 alleles that carry increased risk to or protection from development of type 1 diabetes. Children carrying increased risk are followed at 3-month intervals until 2 years of age and then ...

Phase

Japanese Primary Prevention Project With Aspirin

Cerebro/cardiovascular (CV) death accounts for approximately 30% of total deaths in Japan and therefore it is important to establish a preventive treatment for CV events from the point of public health. The guidelines proposed by a joint study group centering on the Japanese Circulation Society, recommend administration of aspirin to ...

Phase

Diabetes Prevention Program in Schizophrenia [DPPS]

Rationale: - From large international RCT studies, Type 2 Diabetes can be prevented / delayed for overweight, pre-diabetic individuals by making basic lifestyle changes (regular moderate exercise, healthy eating habits) and using metformin or other insulin resistance inhibitor. - Individuals with schizophrenia are in particular need of preventative intervention and ...

Phase

Pathway to Prevention Study

Detailed Description: The Pathway to Prevention Study is conducted in two parts: Screening Monitoring (annual and semi-annual depending on risk) In Screening , a simple blood test is done to screen for the presence of diabetes-related biochemical autoantibodies (GAD and mIAA). Additional autoantibodies ICA, IA-2A, and ZnT8A will also measured ...

Phase N/A

Integrating Community Health Workers to Improve Diabetes Prevention

This population based trial aims to understand the impact of peer health interventions on panels of patients in a real clinic environment Investigators will conduct a cluster-randomized trial to test the impact of peer health coaches on prediabetic patients cared for by patient-centered medical home model (PCMH) teams to Reduce ...

Phase N/A

Diabetes Prevention for Mexican Americans

The main purpose of this study is to test a culturally tailored lifestyle intervention that incorporates motivational interviewing and is designed to prevent, or delay onset of, T2DM in Mexican Americans with prediabetes. Groups of participants will be randomly assigned to: a) an experimental group that receives a lifestyle program ...

Phase N/A

United for Health: Type 2 Diabetes Prevention in Latino Teens

This study is a comparative effectiveness pilot trial to evaluate the feasibility and acceptability of a 12-session community-delivered, family-based type 2 diabetes preventative lifestyle intervention, delivered over 6 weeks, that includes mindfulness-based stress reduction training - "Salud sin Barreras" (meaning, "Health without Barriers") - in up to 50 Hispanic/Latino adolescents ...

Phase N/A

Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia

PART A Study visit 1 (30min, day 1): 1. Observations documented in CRF: resting heart rate and blood pressure 2. CGM sensor inserted. 3. Insulin dose reduced by approximately 15%. 4. Participants instructed to return on day 3 (study visit 2) fasted (no breakfast), and to refrain from exercising until ...

Phase

CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1

Study Purpose and Rationale: In this study, relatives who are confirmed to have two or more antibodies, not including mIAA, and normal glucose tolerance will be eligible for randomization to experimental treatment or placebo groups with the aim to determine whether experimental treatment will prevent or delay the occurrence of ...

Phase

Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

After complete islet graft loss is determined, patient's maintenance immunosuppression (i.e. sirolimus and tacrolimus) will be discontinued and they will be placed on Myfortic monotherapy for 2 years thereafter. After completion of two years of Myfortic maintenance monotherapy, it will be weaned and subjects will be monitored over the subsequent ...

Phase N/A